Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-01 06:09 am Purchase |
2025-03-31 | 13G | Clearside Biomedical, Inc. CLSD |
Stephen Boyd Wiles | 4,003,553 5.200% |
4,003,553 (New Position) |
Filing History |
| 2025-03-04 5:20 pm Purchase |
2024-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 6,523,511 8.600% |
258,547 (+4.13%) |
Filing History |
| 2025-02-21 4:30 pm Purchase |
2024-09-13 | 13D | Clearside Biomedical, Inc. CLSD |
Hatteras Venture Advisors IV SBIC, LLC | 313,641 0.400% |
313,641 (New Position) |
Filing History |
| 2023-11-01 4:04 pm Purchase |
2023-10-27 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 6,264,964 10.100% |
247,112 (+4.11%) |
Filing History |
| 2023-02-14 10:29 am Sale |
2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
RTW Investments, LP | 0 0.000% |
-3,806,018 (Position Closed) |
Filing History |
| 2023-02-13 12:19 pm Sale |
2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
Carmignac Gestion | 2,400,344 3.980% |
-723,908 (-23.17%) |
Filing History |
| 2023-01-04 4:15 pm Sale |
2022-12-15 | 13D | Clearside Biomedical, Inc. CLSD |
Hatteras Venture Advisors III LLC | 3,654,062 6.100% |
-1,360,858 (-27.14%) |
Filing History |
| 2023-01-04 12:06 pm Purchase |
2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 6,017,852 9.900% |
139,655 (+2.38%) |
Filing History |
| 2022-02-14 08:44 am Sale |
2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
RTW Investments, LP | 3,806,018 6.400% |
-152,112 (-3.84%) |
Filing History |
| 2022-02-09 2:09 pm Sale |
2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
Carmignac Gestion | 3,124,252 5.200% |
-416,709 (-11.77%) |
Filing History |
| 2022-01-24 4:03 pm Sale |
2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 5,878,197 9.900% |
-486,989 (-7.65%) |
Filing History |
| 2021-02-12 12:25 pm Purchase |
2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
Carmignac Gestion | 3,540,961 7.300% |
3,540,961 (New Position) |
Filing History |
| 2021-02-12 09:55 am Purchase |
2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD |
RTW Investments, LP | 3,958,130 8.190% |
208,023 (+5.55%) |
Filing History |
| 2021-01-07 11:10 am Purchase |
2021-01-06 | 13G | Clearside Biomedical, Inc. CLSD |
WHITMORE BRADFORD T | 6,365,186 11.100% |
929,845 (+17.11%) |
Filing History |